ES / EN
- July 2, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home World

Russia could have a COVID-19 vaccine on the market in less than three months.

Regulatory approval for its mass use could come “in August or September.”

by
  • EFE
    EFE,
  • EFE
    EFE
July 16, 2020
in World
0
Photo: NARONG SANGNAK/EFE/EPA/Archive

Photo: NARONG SANGNAK/EFE/EPA/Archive

Help us keep OnCuba alive

Russia aims to have on the market the first COVID-19 vaccine before October, director general of the Russian Fund of Direct Investments, Kirill Dmitriev, announced this Thursday.

“Yesterday we successfully completed the first phase of the clinical trials of the vaccine developed by the Gamalei Institute and we hope to finish the second phase on August 3, then we will immediately launch the third phase, and not only in Russia, but in a series of other countries,” Dmitriev said at a teleconference press conference.

He added that scientists hope to soon have regulatory approval for the massive use of the vaccine “in August or September” so that it can be on the market before October.

According to the official, the Russian vaccine will be “unique” because it is the first in the world to be tested on animals―hamsters―infected with a fatal dose of the virus after receiving the vaccine and they did not get sick.

“Naturally, there is still a long way to go to show that effect in humans at various stages,” said Dmitriev, who added that he has already received a dose of the Russian experimental vaccine because he is convinced of its efficacy and innocuousness.

Related Posts

Photo: ABC.

All the president’s refugees

June 13, 2025
View of Pope Francis’s tomb in the Basilica of Santa Maria Maggiore in Rome. Photo: EFE/Vatican Press/Francesco Sforza.

Aurelio Alonso on the Pope: “Francis as a name meant a lot from the beginning”

May 4, 2025
April 23, 2025, photo of U.S. President Donald Trump signing executive orders in the Oval Office of the White House. Photo: EFE/EPA/Samuel Corum/Pool.

The ups and downs of the humanitarian parole

April 30, 2025
A screen shows the fall of the Dow Jones Industrial Average at the close of trading at the New York Stock Exchange in New York, USA, on April 4, 2025. Photo: Justin Lane/EFE/EPA.

Trump calls on Americans to “hang tough” and says his tariffs are an “economic revolution”

April 7, 2025

“Now I can officially donate plasma to save other lives,” he said, noting that thanks to the Russian vaccine, he has developed high doses of antibodies against COVID-19.

Dmitriev explained that the vaccine would applied in two doses, the second of which is given 20 days after the first, and together they make the vaccine more “effective and durable” to guarantee immunity to the virus for around two years.

“We plan to produce 30 million doses of that vaccine in Russia during the current year,” he added.

The official stated that Russia has already perceived the interest of other countries for its vaccine under development, including some Latin American states, and is open for collaboration with colleagues around the world to produce, in particular, the Russian vaccine in other countries.

Deputy Prime Minister Tatiana Golikova said that 26 coronavirus vaccines are currently being developed in Russia and that the results of the research give hope that they can be used in the near future.

“The Russian school of vaccines is one of the three most developed schools in the world, so we have managed to select a vaccine (the one that protects against the Ebola virus) and modify it a little,” said Dmitriev when explaining the process of finding a cure for the coronavirus in Russia.

U.S.: First COVID-19 vaccine shows encouraging results

In this sense, he also highlighted the effectiveness of the Russian drug Afivavir, developed based on a Japanese antiviral, and pointed out that it has shown its great utility in mild and medium-severity cases of coronavirus.

Russia registered 6,428 new cases of coronavirus this Wednesday, bringing the total number of infections since the outbreak of the pandemic to 752,797.

COVID-19 has also caused 11,970 deaths in this country, according to official figures.

Help us keep OnCuba alive

  • EFE
    EFE,
  • EFE
    EFE
Tags: coronavirusCOVID-19 vaccine
Previous Post

Cuba: two COVID-19 cases today, both from Havana

Next Post

Measures presented to decongest public transportation in Cuban capital

EFE

EFE

EFE

EFE

Next Post
Photo: Otmaro Rodríguez.

Measures presented to decongest public transportation in Cuban capital

Photo: Otmaro Rodríguez.

Cuban economy will fall 8% due to pandemic, according to ECLAC

The municipalities where they were detected are: La Lisa, Boyeros, 10 de Octubre and Arroyo Naranjo. According to Durán, “all were related to outbreaks located on previous days.” Photo: Otmaro Rodríguez

Four new COVID-19 positive cases in Cuba, distributed in four Havana municipalities

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • The Enchanted Shrimp of the Cuban Dance

    3055 shares
    Share 1222 Tweet 764
  • Private sector and tourism in Cuba. Why not?

    10 shares
    Share 4 Tweet 3
  • Rachel Sánchez: the taste of Cuba on MasterChef USA

    11 shares
    Share 4 Tweet 3
  • CIA documents revealing attempts to assassinate Fidel and Raúl Castro declassified

    44 shares
    Share 18 Tweet 11
  • A sanctuary for jazz in Cuba: César López’s dream

    8 shares
    Share 3 Tweet 2

Most Commented

  • Photo: Kaloian.

    Private sector and tourism in Cuba. Why not?

    10 shares
    Share 4 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}